INIS
adults
7%
aggregation
7%
assessments
19%
blood
10%
cancer
15%
chemotherapy
14%
collagen
10%
comparative evaluations
15%
control
6%
cost
6%
defects
10%
diseases
33%
evaluation
14%
glycoproteins
9%
hemophilia
38%
hemorrhage
6%
hemostatics
9%
laboratories
10%
levels
27%
patients
100%
peaks
6%
performance
6%
phenotype
6%
populations
12%
risks
11%
screening
10%
sensitivity
7%
testing
7%
thrombin
11%
transfusions
8%
Keyphrases
Bleeding
12%
Bleeding Assessment Tool
6%
Bleeding Disorders
8%
Cancer Patients
9%
Chemotherapy
10%
Clinical Practice
6%
Desmopressin (DDAVP)
15%
Factor Concentrates
6%
Factor VIII (FVIII)
6%
Factor VIII Level
6%
Hemophilia
30%
Hemophilia B
9%
Hemophilia Patients
6%
Hemostasis
9%
Integrin
9%
Mild Bleeding Disorders
13%
Multi-parameter
9%
Netherlands
6%
Non-severe Haemophilia
13%
Pharmacokinetics
14%
Platelet Function Analyzer
9%
Platelet Function Disorders
6%
Platelet Transfusion
6%
Platelets
22%
Severe Haemophilia A
7%
Thrombin Generation Assay
8%
Thrombocytopenia
14%
Thrombus Formation
13%
Von Willebrand Disease
16%
Von Willebrand Factor
18%
Medicine and Dentistry
Bleeding
16%
Bleeding Disorder
23%
Blood Clotting
8%
Blood Clotting Factor 8
8%
Blood Stasis
9%
Cross Sectional Study
5%
Desmopressin
15%
Diagnosis
14%
Disease
7%
Fibrinolysis
6%
Glycoprotein VI
9%
Haemophilia
10%
Haemophilia A
23%
Haemophilia B
9%
Health Care Cost
5%
Hemostat
9%
Integrin
9%
Pharmacokinetics
13%
Platelet
18%
Population
5%
Prospective Study
5%
Thrombocyte Function
14%
Thrombocyte Transfusion
6%
Thrombocytopenia
11%
Von Willebrand Disease
13%
Von Willebrand Factor
9%
